Side Effect

Extrapyramidal symptoms (EPS): the movement side effects of antipsychotics

March 30, 2026 7 min read

"Extrapyramidal symptoms" (EPS) is the umbrella term for the movement-related side effects of antipsychotic medication. They're caused by the dopamine receptor blockade in brain regions that control movement (the basal ganglia). EPS is one of the main reasons people stop their antipsychotics — but each type has its own warning signs and effective treatments.

The four types of EPS

1. Acute dystonia — sudden muscle contractions, usually in the first days
2. Akathisia — inner restlessness, usually first weeks
3. Drug-induced parkinsonism — stiffness and slowness, weeks to months
4. Tardive dyskinesia — involuntary movements, months to years

1. Acute dystonia

What it is: Sudden, sustained muscle contractions. The muscles lock in an abnormal position. Most commonly affects:

It can be terrifying for the patient and family but is generally not dangerous. Usually occurs in the first 1–5 days after starting an antipsychotic or after a dose increase. More common in young men and with first-generation antipsychotics (haloperidol).

Treatment: Anticholinergic medication (benztropine 1–2 mg IM, or diphenhydramine 25–50 mg IM) reverses it within minutes. After acute treatment, an oral anticholinergic is usually prescribed for a few weeks.

2. Akathisia

What it is: An intense inner restlessness — feeling unable to sit still, needing to keep moving. The classic sign is constant pacing, foot tapping, or shifting from foot to foot. Easy to misread as anxiety, agitation, or even worsening psychosis.

Akathisia is one of the most distressing side effects and a major driver of medication discontinuation. Untreated, it has been associated with increased suicide risk. Take it seriously and report it.

When it happens: Usually within the first weeks of treatment or after a dose increase. Most common with high-potency first-generation antipsychotics, but also frequent with risperidone, aripiprazole, and lurasidone.

Treatment:

3. Drug-induced parkinsonism

What it looks like: Same features as Parkinson's disease — bradykinesia (slowness), rigidity, tremor, mask-like face, shuffling gait, micrographia (small handwriting). Onset is usually over weeks to a few months on the antipsychotic.

Why it happens: The antipsychotic blocks dopamine in the basal ganglia, mimicking the dopamine deficiency of Parkinson's disease. Reversible if the offending medication is reduced or stopped.

Treatment:

4. Tardive dyskinesia (TD)

Covered in detail in our TD guide. The short version: involuntary, repetitive movements (often of the face, mouth, tongue, fingers, toes) that develop after months to years of antipsychotic treatment. Can persist or become permanent. Risk is lower with second-generation antipsychotics but real.

Treatment: VMAT2 inhibitors (valbenazine, deutetrabenazine) are the new evidence-based treatment.

Other related movement side effects

Neuroleptic Malignant Syndrome (NMS)

Rare but life-threatening. Triad of high fever, severe muscle rigidity ("lead pipe"), and altered mental status, plus autonomic instability (high or unstable blood pressure and heart rate). Requires emergency care and immediate discontinuation of the antipsychotic.

Which antipsychotics cause the most EPS?

From highest to lowest EPS risk (rough ordering):

What to do

  1. Tell your prescriber about any new movement, restlessness, or stiffness
  2. Never stop the antipsychotic on your own — sudden stops can trigger psychotic relapse and sometimes withdrawal dyskinesia
  3. Annual screening with the AIMS scale for any patient on long-term antipsychotic treatment
  4. Use the lowest effective dose
  5. Consider lower-EPS alternatives if symptoms are persistent

This article is for educational purposes only and is not medical advice. Always consult your prescribing clinician for personalised guidance.

Frequently asked questions

Is akathisia the same as anxiety?
No. Akathisia is a physical sensation of needing to move (often in the legs) caused by dopamine blockade. Anxiety is a psychological state. They can co-exist and are often confused, but akathisia responds to specific treatments (beta-blockers, dose reduction) that don't help anxiety.
Will I get tardive dyskinesia if I take an antipsychotic long term?
Risk increases with cumulative exposure but most patients on second-generation antipsychotics do not develop clinically significant TD. Annual AIMS screening can catch it early when intervention is most effective.
Are anticholinergic medications (benztropine) safe long-term?
They can be effective but cause cognitive impairment, dry mouth, constipation, and urinary retention — especially in older patients. They should be used at the lowest effective dose and re-evaluated periodically. Many clinicians prefer to address EPS by adjusting the antipsychotic instead.

Try Frida — your calm companion

Frida helps people living with schizophrenia track moods, manage medication, and build stability. 7-day free trial.

Get the app →